135 related articles for article (PubMed ID: 30652589)
21. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
[TBL] [Abstract][Full Text] [Related]
22. Risk management adherence following genetic testing for hereditary cancer syndromes: a Singaporean experience.
Courtney E; Chin XW; Yuen J; Li ST; Chen Y; Allen JC; Tan V; Lim GH; Ngeow J
Fam Cancer; 2018 Oct; 17(4):621-626. PubMed ID: 29368260
[TBL] [Abstract][Full Text] [Related]
23. Hereditary breast and ovarian cancer and other hereditary syndromes: using technology to identify carriers.
Drohan B; Roche CA; Cusack JC; Hughes KS
Ann Surg Oncol; 2012 Jun; 19(6):1732-7. PubMed ID: 22427173
[TBL] [Abstract][Full Text] [Related]
24. Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes.
Soukupova J; Zemankova P; Lhotova K; Janatova M; Borecka M; Stolarova L; Lhota F; Foretova L; Machackova E; Stranecky V; Tavandzis S; Kleiblova P; Vocka M; Hartmannova H; Hodanova K; Kmoch S; Kleibl Z
PLoS One; 2018; 13(4):e0195761. PubMed ID: 29649263
[TBL] [Abstract][Full Text] [Related]
25. Genetic testing by cancer site: ovary.
Weissman SM; Weiss SM; Newlin AC
Cancer J; 2012; 18(4):320-7. PubMed ID: 22846732
[TBL] [Abstract][Full Text] [Related]
26. Hereditary ovarian cancer.
Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
[TBL] [Abstract][Full Text] [Related]
27. [Genetic diagnosis of cancers? Which cancers should be screened?].
Chompret A
Ann Med Interne (Paris); 2001 Jun; 152(4):249-61. PubMed ID: 11474373
[TBL] [Abstract][Full Text] [Related]
28. ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Syngal S; Brand RE; Church JM; Giardiello FM; Hampel HL; Burt RW;
Am J Gastroenterol; 2015 Feb; 110(2):223-62; quiz 263. PubMed ID: 25645574
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
30. National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
Childers KK; Maggard-Gibbons M; Macinko J; Childers CP
JAMA Oncol; 2018 Jun; 4(6):876-879. PubMed ID: 29710084
[TBL] [Abstract][Full Text] [Related]
31. Hereditary cancer syndromes.
Fostira F; Thodi G; Konstantopoulou I; Sandaltzopoulos R; Yannoukakos D
J BUON; 2007 Sep; 12 Suppl 1():S13-22. PubMed ID: 17935271
[TBL] [Abstract][Full Text] [Related]
32. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
[TBL] [Abstract][Full Text] [Related]
33. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
Pritzlaff M; Summerour P; McFarland R; Li S; Reineke P; Dolinsky JS; Goldgar DE; Shimelis H; Couch FJ; Chao EC; LaDuca H
Breast Cancer Res Treat; 2017 Feb; 161(3):575-586. PubMed ID: 28008555
[TBL] [Abstract][Full Text] [Related]
34. Hereditary pancreatic cancer: a clinical perspective.
Greer JB; Lynch HT; Brand RE
Best Pract Res Clin Gastroenterol; 2009; 23(2):159-70. PubMed ID: 19414143
[TBL] [Abstract][Full Text] [Related]
35. [Risk assessment for familial occurrence of breast cancer].
Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
[TBL] [Abstract][Full Text] [Related]
36. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.
Mork ME; You YN; Ying J; Bannon SA; Lynch PM; Rodriguez-Bigas MA; Vilar E
J Clin Oncol; 2015 Nov; 33(31):3544-9. PubMed ID: 26195711
[TBL] [Abstract][Full Text] [Related]
37. Strategies for clinical implementation of screening for hereditary cancer syndromes.
Heald B; Marquard J; Funchain P
Semin Oncol; 2016 Oct; 43(5):609-614. PubMed ID: 27899194
[TBL] [Abstract][Full Text] [Related]
38. Integration of family history and medical management of patients with hereditary cancers.
Tinley ST; Lynch HT
Cancer; 1999 Dec; 86(11 Suppl):2525-32. PubMed ID: 10630178
[TBL] [Abstract][Full Text] [Related]
39. Identifying hereditary cancer: genetic counseling and cancer risk assessment.
Lewis KM
Curr Probl Cancer; 2014; 38(6):216-25. PubMed ID: 25432528
[TBL] [Abstract][Full Text] [Related]
40. Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.
Rana HQ; Gelman R; LaDuca H; McFarland R; Dalton E; Thompson J; Speare V; Dolinsky JS; Chao EC; Garber JE
J Natl Cancer Inst; 2018 Aug; 110(8):863-870. PubMed ID: 29529297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
